Publications by authors named "J M Cerqueiro"
Background: Patients with heart failure (HF) and chronic obstructive pulmonary disease (COPD) have a high risk of hospital admission and mortality. This study evaluated the benefit of a care model, characterized by comprehensive and continuous care (UMIPIC program) in patients with HF and a history of COPD.
Methods: A total of 5644 patients were prospectively recruited, of which 1320 had a history of COPD between March 2008 and March 2020.
Article Synopsis
- Patients with heart failure (HF) and cardiorenal syndrome (CRS) face challenges like higher hospital stays and mortality rates due to their age and health issues.
- The UMIPIC program, involving specialized care from internists and nurses, was studied to see if it could improve outcomes for these patients.
- Results showed that those in the UMIPIC program had significantly fewer hospital readmissions (20% vs 32%) and lower mortality rates (24% vs 36%) compared to those receiving standard care, indicating its effectiveness in providing better long-term management.
Article Synopsis
- A multicenter study in Spain examined the potential benefits of dapagliflozin for patients with heart failure (HF) with mildly reduced or preserved ejection fraction.
- Out of 4049 patients over 50 years old, 80.8% met the criteria for dapagliflozin treatment, with significant rates of rehospitalization (22.2%) and mortality (21.6%) within a year after discharge.
- The use of dapagliflozin is projected to reduce the absolute risk of mortality by 1.3% and HF readmissions by 5.1%, indicating a potential to lessen the burden of HF in these patients.
Aims: To evaluate whether the addition of hydrochlorothiazide (HCTZ) to intravenous furosemide is a safe and effective strategy for improving diuretic response in acute heart failure (AHF).
Methods And Results: A prospective, double-blind, placebo-controlled trial, including patients with AHF randomized to receive HCTZ or placebo in addition to an intravenous furosemide regimen. The coprimary endpoints were changes in body weight and patient-reported dyspnoea 72 h after randomization.
Introduction: Beta-adrenergic receptor blockers (beta-blockers) are frequently used for patients with heart failure (HF) with preserved ejection fraction (HFpEF), although evidence-based recommendations for this indication are still lacking. Our goal was to assess which clinical factors are associated with the prescription of beta-blockers in patients discharged after an episode of HFpEF decompensation, and the clinical outcomes of these patients.
Methods: We assessed 1078 patients with HFpEF and in sinus rhythm who had experienced an acute HF episode to explore whether prescription of beta-blockers on discharge was associated with one-year all-cause mortality or the composite endpoint of one-year all-cause death or HF readmission.